Independent and FREE - 2021 Best Online Publication

USC study gives new hope in battle against depression

Independent and FREE – 2021 Best Online Publication (Qld Country Press)

USC study gives new hope in battle against depression


'Enormous potential': USC study may lead to more sustainable treatment of depression

Do you have a news tip? Click here to send to our news team.

Daredevil doctors put to the test in extreme conditions

Three new doctors have proved they have what it takes to practise medicine in the most extreme conditions. Whether it's dangling 250m above the sea, More

Buyers rush for slice as new neighbourhood opens

The southern Sunshine Coast’s newest waterfront community has officially opened at Pelican Waters, with only a handful of premium lots remaining. Castaways Pocket is nestled More

Why unusual nuggets are ‘flying off the shelves’

A Noosa mum has found the secret to encouraging kids to eat more 'plant-based' food — turn it into a nugget shape. Tammy Fry, from More

Esteemed architect behind iconic structure lifts the lid on Loo’s future

The award-winning architect behind Mooloolaba's iconic toilet block has given his view on the future of the 25-year-old weathered structure. Acclaimed Lindsay Clare designed the More

What’s happening inside opulent tent at Cotton Tree

A luxury travelling pavilion is set to excite and entertain crowds on the Sunshine Coast for the first time, during a 10-day festival. The Wonderland More

‘Time to laugh again’: Australia’s funniest people let loose on the Coast

A star-studded live comedy festival is coming to Caloundra this month and it promises to be "unscripted and dangerous". Growing up watching his own father More

University of the Sunshine Coast researchers have discovered that a well-known anaesthetic could help people to lead a happier, healthier life.

Neuroscience researchers from USC Australia have found a link between low-dose ketamine treatment and improved health in areas of the brain associated with depression and suicidality.

The study, from USC’s Thompson Institute, was published in Psychiatry Research: Neuroimaging, and the team behind it is now looking to conduct a similar study for post-traumatic stress disorder.

Lead authors Cyrana Gallay and Grace Forsyth said that after a six-week treatment of low-dose ketamine, there was improvement in areas of the brain associated with depression and suicidality.

“In people suffering from depression, we expect to see atrophied brain tissue in certain regions, meaning that brain cells may be shrunken, shut down or not communicating properly,” Ms Gallay said.

“After six weeks of low-dose ketamine treatment, we found increased grey matter volume in key brain areas associated with suicidality and depression, effectively mirroring what a healthier brain would look like.”

The team clinically administered oral ketamine in micro-doses ranging from 0.05 to 3mg/kg, which is far below the dosing commonly used in medical anaesthesia.

Follow us on Facebook:

Ms Forsyth said previous studies had shown low-dose ketamine promoted cell function and increased cell branches and communication pathways within a matter of days.

“Low-dose ketamine activates the glutamatergic system, an essential, naturally occurring chemical in the brain responsible for the promotion of learning and memory, among other key brain functions,” Ms Forsyth said.

The findings follow an earlier published paper by the same author group in Translational Psychiatry, which found that 69 per cent of participants reported clinically significant reduction in suicide ideation.

Previous studies showed low-dose ketamine promoted cell function and increased cell branches and communication pathways within days. Picture: Shutterstock.

Director of the Thompson Institute and senior researcher on the study, Professor Jim Lagopoulos, said an increasing number of similar studies were showing positive impacts from low-dose psychedelic treatments.

“Psychedelics delivered in a clinical setting are a growing field of interest and there is enormous potential for developing treatments that are accessible, sustainable and potentially more effective than the treatments we have now,” Professor Lagopoulos said.

Help keep independent and free news alive by subscribing to our free daily news feed: Go to SUBSCRIBE at top of this article to register.

“Ketamine is used as a medical anaesthetic, particularly for children because it is so safe and well-tolerated.

“It has an incredible history of helping burns victims and veterans recovering from surgery and was discovered almost by mistake for use in mental health after medical patients began reporting better moods after their treatment.”

“However, during the post-war era, misuse and social stigma eroded the public perception of ketamine.

“But despite concern that it can be addictive, in a clinical setting we find that people tend to be able to go longer periods of time between low-dose ketamine treatments.”

Professor Lagopoulos said there was a pressing need to consider new and alternative treatments for mental health conditions.

“The mental health system is facing unprecedented demand, so we need to look past the treatments that really haven’t been updated for a long time and consider new options that have a growing body of scientific evidence that suggests they are safe and effective,” he said.

People looking to sign up to a similar study for PTSD can visit